Regarding HA metabolic turnover, the statistically significant up-regulation of HAS1 in individuals with obesity with no relevant gene expression changes in HAS2 and HAS3 or HA degrading enzymes was confirmed in our previous microarray public data. The gene discussed is HAS3; the disease is obesity due to melanocortin 4 receptor deficiency.